Sinclair Pharma (XPAR:SPH) Price-to-Free-Cash-Flow : N/A (As of Jun. 19, 2024)

Sinclair Pharma Price-to-Free-Cash-Flow Chart

Sinclair Pharma Annual Data
	Trend	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Dec17
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					-	-	-	100.00	-

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sinclair Pharma's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's Price-to-Free-Cash-Flow falls into.

Sinclair Pharma Price-to-Free-Cash-Flow Calculation

Sinclair Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Sinclair Pharma's Share Price of today is €0.27.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinclair Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2018 was €-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Sinclair Pharma  (XPAR:SPH) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Sinclair Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description